Effect of Danshenyin on Gastrointestinal Inhibition and Immune Index of Patients with Bladder Cancer After Chemotherapy

JIANG Yuan-bin; WANG You; GUO Yu; LIU Yu; WANG Xi; YANG Xing-zhi

doi:10.13422/j.cnki.syfjx.2017150191

您当前的位置：

首页 >

文章列表页 >

Effect of Danshenyin on Gastrointestinal Inhibition and Immune Index of Patients with Bladder Cancer After Chemotherapy

更新时间：2024-01-04

- Effect of Danshenyin on Gastrointestinal Inhibition and Immune Index of Patients with Bladder Cancer After Chemotherapy
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 23, Issue 15, Pages: 191-195(2017)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.2017150191
  CLC： R737.14
- Published：2017
- 稿件说明：
移动端阅览
JIANG Yuan-bin, WANG You, GUO Yu, et al. Effect of Danshenyin on Gastrointestinal Inhibition and Immune Index of Patients with Bladder Cancer After Chemotherapy[J]. Chinese journal of experimental traditional medical formulae, 2017, 23(15): 191-195.
DOI：

JIANG Yuan-bin, WANG You, GUO Yu, et al. Effect of Danshenyin on Gastrointestinal Inhibition and Immune Index of Patients with Bladder Cancer After Chemotherapy[J]. Chinese journal of experimental traditional medical formulae, 2017, 23(15): 191-195. DOI： 10.13422/j.cnki.syfjx.2017150191.

摘要

目的：探讨丹参饮对膀胱癌患者化疗后胃肠道抑制及免疫功能的影响，并探讨其作用机制。方法：将重庆市中医院收治的膀胱癌患者140例均行化疗治疗，随机抽取70例于化疗期间服用丹参饮（观察组），其余70例为对照组。比较两组胃肠道抑制比例，化疗前后细胞免疫和体液免疫指标水平、自然杀伤（natural killer，NK）细胞水平及血清相关因子水平。结果：化疗后24 h内，对照组Ⅲ~Ⅳ比例高于观察组（P<0.05），对照组0级比例低于观察组（P<0.05）。在72 h内，观察组0级比例高于对照组（P<0.05），Ⅰ~Ⅱ和Ⅲ~Ⅳ比例均低于对照组（P<0.05）。化疗后，两组患者CD3+，CD4+和CD4+/CD8+均较化疗前降低（P<0.05），CD8+水平均较化疗前升高（P<0.05）；观察组CD3+，CD4+和CD4+/CD8+的变化程度均小于对照组（P<0.05）。化疗后，两组患者免疫球蛋白A（immunoglobulin A，IgA）和免疫球蛋白M（immunoglobulin M，IgM）水平均较化疗前降低（P<0.05）。化疗后，两组患者NK细胞水平均低于化疗前（P<0.05），观察组下降幅度小于对照组（P<0.05）。化疗后，观察组的白细胞介素-12（interleukin-12，IL-12）和肿瘤坏死因子（tumor necrosis factor，TNF）-α水平低于对照组（P<0.05）。结论：在化疗时，加服丹参饮可有效降低患者的胃肠道抑制，并更好的调节患者免疫功能。

Abstract

Objective: To analyze the effect of Danshenyin on gastrointestinal inhibition and immune index of patients with bladder cancer after chemotherapy and its action mechanism. Method: A total of 140 patients with bladder cancer were included in the study. All of the patients received chemotherapy. Among them

70 patients were selected to take Danshenyin during chemotherapy (observation group)

while the remaining patients were control group. Proportion of gastrointestinal inhibition

cellular immunity

humoral immunity

natural killer (NK) and serum-related factor level were compared before and after chemotherapy. Result: Within 24 hours after chemotherapy

the proportion of Ⅲ-Ⅳ of control group were higher than that of observation group (P<0.05). The proportion of level 0 of control group was lower than that of observation group (P<0.05). Within 72 hours after chemotherapy

the proportion of level 0 of observation group was still higher than that of control group

and the proportions of Ⅰ-Ⅱ and Ⅲ-Ⅳ were lower than those of the control group. After chemotherapy

CD3+

CD4+ and CD4+/CD8+ levels of two groups were lower than those before chemotherapy (P<0.05). CD8+ level was higher than that before chemotherapy (P<0.05). CD3+

CD4+ and CD4+/CD8+ levels of observation group were better than those of control group (P<0.05). After chemotherapy

immunoglobulin A (IgA) and immunoglobulin M (IgM) levels of two groups were lower than those before chemotherapy (P<0.05). After chemotherapy

NK level of two groups was lower than that before chemotherapy (P<0.05). The observation group decreased less than control group (P<0.05). Interleukin-12 (IL-12) and tumor necrosis factor-α (TNF-α) levels of the observation group were lower than those of control group (P<0.05). Conclusion: During chemotherapy

Danshenyin can effectively reduce gastrointestinal inhibition and adjust immune function.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Effect of Erxian Shengbai Decoction Combined with Huangqi Huanagshan Soup on Leukopenia After Chemotherapy and Regulatory Effect on Immunity

Effect of Modified Qingzao Jiufei Tang on Quality of Life and Survival Period of Patients with Non-small Cell Lung Cancer

Kang'ai Injection Combined with Chemotherapy in Treatment of Malignant Tumor

Effect of Complex Banmao Capsules Combined with FOLFOX4 Regimen on Immune Function and Quality of Life in Advanced Gastrointestinal Malignancies Patients

In Vitro and in vivo Component Identification of Danshenyin Based on UPLC-Q-TOF-MS/MS

Related Author

YANG Shu-yan

WU Mao-lin

WU Xin

GU Fang-hong

ZHOU Jian-wei

XIE Li-fang

WANG Tian-wu

CHE Jian-hua

Related Institution

Affiliated Hospital of Chengdu University of Traditional Chinese Medicine

West China Hospital of Sichuan University

Qingpu Branch, Zhongshan Hospital Affiliated to Fudan University

Key Laboratory for Standardization of Chinese Medicines，Ministry of Education， Shanghai Key Laboratory for Compound Chinese Medicines，Institute of Chinese Materia Medica， Shanghai University of Traditional Chinese Medicine

Hubei University of Chinese Medicine

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰